De Leon, Marilou T.
HRN: 19-74-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFUROXIME 1.5GM (VIAL)
09/29/2022
09/30/2022
IV
1.5g
Q8
S/P VBAC; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes